판매 매출 총 이익 변화 날짜
Acadia Pharmaceuticals USD 243.27M 14.49M 2026-03
Agios Pharmaceuticals USD 19.43M 1.34M 2026-03
Akebia Therapeutics USD 47.28M 1.7M 2025-12
Almirall EUR 429.87M 180.02M 2025-12
Alnylam Pharmaceuticals USD 825M 4.3M 2026-03
Amarin USD 23.17M 961K 2025-12
Ardelyx USD 114.37M 8.02M 2025-12
Astellas Pharma JPY 444.26B 12.55B 2026-03
AstraZeneca USD 12.61B 225M 2026-03
Charles River Laboratories USD 279.32M 7.36M 2026-03
Coherus Biosciences USD 8.7M 853K 2025-12
Esperion Therapeutics USD 140.59M 94.57M 2025-12
Halozyme Therapeutics USD 297.47M 75.53M 2026-03
Incyte USD 1.17B 217.51M 2026-03
Ironwood Pharmaceuticals USD 85.24M 44.1M 2025-06
Karyopharm Therapeutics USD 32.6M 63.38M 2025-12
Lexicon Pharmaceuticals USD 5.29M 8.88M 2025-12
MacroGenics USD 31.11M 30.14M 2025-12
Moderna USD -566M 792M 2026-03
Myriad Genetics USD 146.8M 3M 2025-12
Pacira USD 126.64M 15.61M 2026-03
PTC Therapeutics USD 232.94M 84.56M 2026-03
Puma Biotechnology USD 20.32M 24.85M 2024-09
Sarepta Therapeutics USD 621.34M 577.79M 2026-03
Takeda JPY 688.84B 101.71B 2026-03
Ultragenyx Pharmaceutical USD 106M 72M 2026-03
Vanda Pharmaceuticals USD 50.6M 5.5M 2024-12